BY JURISDICTION

Peptide legal status by country

Legal status is published for 40 of 54 jurisdictions. Each status comes from a named government register and shows the date it was read. The other jurisdictions are listed below with the reason.

Where each peptide is authorised

Tirzepatide: authorised or registered in 10 of 10 registers read (the US, the EU, the UK, CA, AU, CH, BR, RS, SG, TR).Click a country
United Arab Emirates: Not read yetArgentina: Not read yetAustria: AuthorisedAustralia: RegisteredBelgium: AuthorisedBulgaria: AuthorisedBrazil: RegistadoCanada: AuthorisedSwitzerland: AuthorisedChina: Not read yetCyprus: AuthorisedCzechia: AuthorisedGermany: AuthorisedDenmark: AuthorisedEstonia: AuthorisedEgypt: Not read yetSpain: AuthorisedFinland: AuthorisedFrance: AuthorisedUnited Kingdom: AuthorisedGreece: AuthorisedCroatia: AuthorisedHungary: AuthorisedIreland: AuthorisedIsrael: Not read yetIndia: Not read yetIceland: AuthorisedItaly: AuthorisedJapan: Not read yetSouth Korea: Not read yetLiechtenstein: AuthorisedLithuania: AuthorisedLuxembourg: AuthorisedLatvia: AuthorisedMalta: AuthorisedMexico: Not read yetNetherlands: AuthorisedNorway: AuthorisedNew Zealand: Not read yetPoland: AuthorisedPortugal: AuthorisedRomania: AuthorisedSerbia: AuthorisedSaudi Arabia: Not read yetSweden: AuthorisedSingapore: RegisteredSlovenia: AuthorisedSlovakia: AuthorisedThailand: Not read yetTurkey: RuhsatliUkraine: Not read yetUnited States: FDA-approvedSouth Africa: Not read yet
Authorised or registeredNot on the register, or withdrawnNot read yet, or status unknown

Statuses: 10 registers, read 2026-08-31 to 2026-10-03. An EU decision colours every territory the EU register covers (30: its member states, and Iceland, Liechtenstein and Norway). Country shapes: Natural Earth.

Covered

40

of 54 in the catalogue

Compounds

60

checked in each covered jurisdiction

Registers ratified

10

au-artg, br-anvisa, ca-dpd, ch-swissmedic, ema, openfda, rs-alims, sg-hsa, tr-titck, uk-mhra

Register declared, not ratified

13

AE, AR, CN, EG, IL, IN, JP, KR, NZ, SA, TH, UA, ZA

MAP

54 jurisdictions on the map

Regulatory coverage by jurisdictionA world map of the 53 catalogued jurisdictions that hold territory. Covered by a jurisdiction's own ratified register: 9. Covered through a bloc authorisation: 30. Register declared and not ratified: 13. No register connected: 1. The European Union is catalogued too and is not drawn, because a bloc has no territory of its own; it appears in the coverage grid below, which carries all 54 as text. Shading shows how many of the 60 tracked compounds are authorised in that jurisdiction's own ratified register, on the date it was read. Jurisdictions without a ratified register carry no band and are not shaded: that is an absence of checking, not an absence of authorisations. The shades are scaled to the range actually observed, 26 to 45 of 60, and not to the full 60, so the palest shade means 26 rather than none. Every band's real range is printed in the key.Not in the catalogueUnited Arab Emirates: Register declaredArgentina: Register declaredAustria: Covered through the EU authorisation. 30 of 60 compounds authorisedAustralia: Covered. 29 of 60 compounds authorisedBelgium: Covered through the EU authorisation. 30 of 60 compounds authorisedBulgaria: Covered through the EU authorisation. 30 of 60 compounds authorisedBrazil: Covered. 32 of 60 compounds authorisedCanada: Covered. 38 of 60 compounds authorisedSwitzerland: Covered. 36 of 60 compounds authorisedChina: Register declaredCyprus: Covered through the EU authorisation. 30 of 60 compounds authorisedCzechia: Covered through the EU authorisation. 30 of 60 compounds authorisedGermany: Covered through the EU authorisation. 30 of 60 compounds authorisedDenmark: Covered through the EU authorisation. 30 of 60 compounds authorisedEstonia: Covered through the EU authorisation. 30 of 60 compounds authorisedEgypt: Register declaredSpain: Covered through the EU authorisation. 30 of 60 compounds authorisedFinland: Covered through the EU authorisation. 30 of 60 compounds authorisedFrance: Covered through the EU authorisation. 30 of 60 compounds authorisedUnited Kingdom: Covered. 37 of 60 compounds authorisedGreece: Covered through the EU authorisation. 30 of 60 compounds authorisedCroatia: Covered through the EU authorisation. 30 of 60 compounds authorisedHungary: Covered through the EU authorisation. 30 of 60 compounds authorisedIreland: Covered through the EU authorisation. 30 of 60 compounds authorisedIsrael: Register declaredIndia: Register declaredIceland: Covered through the EU authorisation. 30 of 60 compounds authorisedItaly: Covered through the EU authorisation. 30 of 60 compounds authorisedJapan: Register declaredSouth Korea: Register declaredLiechtenstein: Covered through the EU authorisation. 30 of 60 compounds authorisedLithuania: Covered through the EU authorisation. 30 of 60 compounds authorisedLuxembourg: Covered through the EU authorisation. 30 of 60 compounds authorisedLatvia: Covered through the EU authorisation. 30 of 60 compounds authorisedMalta: Covered through the EU authorisation. 30 of 60 compounds authorisedMexico: No registerNetherlands: Covered through the EU authorisation. 30 of 60 compounds authorisedNorway: Covered through the EU authorisation. 30 of 60 compounds authorisedNew Zealand: Register declaredPoland: Covered through the EU authorisation. 30 of 60 compounds authorisedPortugal: Covered through the EU authorisation. 30 of 60 compounds authorisedRomania: Covered through the EU authorisation. 30 of 60 compounds authorisedSerbia: Covered. 26 of 60 compounds authorisedSaudi Arabia: Register declaredSweden: Covered through the EU authorisation. 30 of 60 compounds authorisedSingapore: Covered. 30 of 60 compounds authorisedSlovenia: Covered through the EU authorisation. 30 of 60 compounds authorisedSlovakia: Covered through the EU authorisation. 30 of 60 compounds authorisedThailand: Register declaredTurkey: Covered. 31 of 60 compounds authorisedUkraine: Register declaredUnited States: Covered. 45 of 60 compounds authorisedSouth Africa: Register declared

Covered 9Covered through a bloc authorisation 30Register declared 13No register 126 to 29 230 to 33 3334 to 37 238 to 41 142 to 45 1

Covered jurisdictions link to their page. The states are shown by fill and by pattern as well as by colour, and each shape names its state on hover. A stippled country is covered through a bloc authorisation, not its own national register.

COVERAGE BY REGION

Coverage by region

Europe
35/36
Americas
3/5
Asia Pacific
2/8
Middle East and Africa
0/5

Covered jurisdictions per region, against the number in the catalogue.

COVERAGE GRID

54 jurisdictions

Covered 40Register declared 13No register 1

COVERED, BY REGION

40 jurisdictions

Europe 35

Americas 3

Asia Pacific 2

The number is how many of the tracked compounds hold a record in that jurisdiction's own register. Rows marked via a bloc are reached through that bloc's central authorisation and carry its numbers, not their own national register's.

NOT COVERED

14 jurisdictions

United Arab EmiratesMoHAP
Register declared, not ratified
DECLARED ON A GOVERNMENT PAGE'S CLAIM, NOT ON AN ENDPOINT FETCHED. The phrasing suggests registration or a key. Search also indicated some MOHAP drug services have moved to a separate Emirates Drug Establishment site, so the national URL may be in flux; that was not verified. Abu Dhabi and Dubai run emirate-level searches as well.
ArgentinaANMAT
Register declared, not ratified
The front door is static and the search surface was not reached. Expect Spanish-inflected names (`semaglutida`); not seen.
ChinaNMPA
Register declared, not ratified
DECLARED ONLY BECAUSE THE BROWSER PROBE PROVED IT EXISTS. It is a JavaScript application with no inventory reached and no bulk file found, and the entire interface and its substance names are in Chinese script, which is a naming problem of a different order from Serbian transliteration. Nothing here is a claim about what the register holds.
EgyptEDA
Register declared, not ratified
A CAPTCHA plus a three-letter minimum means there is no empty-query enumeration path and no inventory was found. Field labels are English while the site chrome is Arabic; whether stored generic names are INN is unobserved.
IsraelMoH
Register declared, not ratified
Hebrew script throughout. The site carries its own disclaimer that some register data may be incomplete or inaccurate and is not an official document, which is a ratification question before it is a technical one.
IndiaCDSCO
Register declared, not ratified
There is no single list and no search over it. 40 PDFs with duplicate years is a reconciliation problem before it is a harvesting one.
JapanPMDA
Register declared, not ratified
SCOPE IS THE PROBLEM, NOT ACCESS. PMDA states the approved-products information covers new drugs and excludes generics and OTC, so a subject absent from it is not absent from Japan. The site also warns that attached files are not translated, so the inventory is likely to be the untranslated original.
South KoreaMFDS
Register declared, not ratified
TIER A ON PAPER AND PROBABLY CLOSED TO US, WHICH IS A CORRECTION TO THIS FILE'S OWN EARLIER NOTE. The right dataset was found and read on 2026-09-03: MFDS Pharmaceutical Product Authorization Information, data.go.kr dataset 15095677, endpoint https://apis.data.go.kr/1471000/DrugPrdtPrmsnInfoService07/getDrugPrdtPrmsnInq07, REST, JSON or XML, free, auto-approved at development level, 10,000 calls a day, fields including the MAIN INGREDIENT, which is the inventory. (Dataset 15117134, named in the first survey, is the HERBAL MEDICINE origin set and is the wrong one.) THE OBSTACLE IS NOT THE KEY, IT IS THE ACCOUNT. This note first said the key was minutes away. Reading the signup flow says otherwise: the English portal offers NO login or signup at all, and the Korean flow at auth.data.go.kr/sso/common-signup is five steps whose member types are 일반회원 (Korean nationals 14+), 어린이 회원 (Korean children) and 기업회원 (businesses registered with the Korean National Tax Service), with step 4 being 본인인증, Korean identity verification. No foreigner category is offered on that page. So the API is public and the portal that issues its key appears to require Korean nationality or a Korean business registration. UNVERIFIED and worth one question to MFDS before this is treated as settled: whether a foreign researcher can obtain a key another way.
MexicoCOFEPRIS
No register connected
UNREACHABLE FROM THIS SESSION, AND THAT IS NOW A MEASUREMENT RATHER THAN A TOOL ARTEFACT. NO REGISTER IS DECLARED, deliberately: a browser timeout is consistent with the host being down, geo-restricted, or moved, and none of those is evidence that Mexico has no public register. Search identifies the Visor de Registros Sanitarios de Medicamentos at this path as live since April; that was not confirmed.
New ZealandMedsafe
Register declared, not ratified
Naming is documented rather than inferred: Medsafe states New Zealand legislates no nomenclature system, accepts BAN, USAN, AAN and INN, and maps synonyms in search. CORRECTED 2026-09-04: THE A-Z INDICES ARE NOT THE INVENTORY, and the 2026-09-03 tiering of NZ as Tier A rested on that claim. Measured by fetching /profs/Datasheet/datasheet.htm: it is an A-Z of DATA SHEETS BY TRADE NAME plus dose form, one line per product, each linking to a PDF - entries read `3TC, Film coated tablet`, `3% Citanest DENTAL with Octapressin`, `2% Xylocaine DENTAL with Adrenaline`. The active ingredient appears only when the sponsor happened to put it in the trade name. Resolving 60 INNs against a trade-name list is the exact false-absence generator the inventory-first method exists to avoid, so NZ is TIER B, not Tier A. The ingredient path is Medsafe's own search at /DbSearch/InfoSearch, which their INN page states resolves synonyms server-side (`frusemide` finds furosemide); characterising that search is the prerequisite to any harvest. ALSO MEASURED: the A-Z is large enough that one fetch TRUNCATED MID-WORD inside the letter D, and a semaglutide search over that partial copy returned nothing - an instrument result, NOT a finding about New Zealand. LESSON-0650 in a new register.
Saudi ArabiaSFDA
Register declared, not ratified
HARVESTED AND NOT RATIFIABLE UNTIL THE SCOPE IS KNOWN. 32 subjects are present and evidenced; the other 28 are recorded `scope-unresolved`, NOT absent, so they publish as unchecked. The page states its scope nowhere. A same-day source sweep found evidence BOTH WAYS and settled nothing: the Arabic title is `Human Drugs List` and the SFDA's own 2011 announcement calls it a list of registered drugs with price as one field among several, and every row's detail page carries Register Number, Authorization Status and Marketing Status separately, which is register-shaped; against that, DULAGLUTIDE is missing while three other -glutides are held, as are ICATIBANT, ETELCALCETIDE and ZILUCOPLAN, which is the shape of a marketed subset. The deciding field renders as the literal string `Array` on SFDA's own page. THE ROUTE OUT IS THE SFDA `Registered Drug Service` JSON API on developer.sfda.gov.sa, data source the Saudi Drug System, bearer token, free registration: it would answer with a value instead of an inference. This is the Swissmedic wrong-file lesson in a new shape - there the file was unreadable in the way that mattered, here it is readable and what it CONTAINS is the open question. Names are uppercase Latin INN with a Title Case minority (Vosoritide), so case-folding is required; multi-ingredient products are comma-joined; LEUPRORELIN not LEUPROLIDE.
ThailandThai FDA
Register declared, not ratified
DECLARED ON A BROWSER PROBE. No inventory reached and no bulk file found; Thai script throughout. The earlier probe reached only the Narcotics Control Division's traveller-permit checker, which is the wrong instrument and is not this.
UkraineSMDC
Register declared, not ratified
Legacy codepage plus Cyrillic is a naming problem of a different order. An open-data resource on data.gov.ua appeared in search and was NOT fetched; it is a lead, not a finding.
South AfricaSAHPRA
Register declared, not ratified
HARVESTED 2026-09-03: the date-range guess was right. /Export takes a date range with no substance name, and 1900 to 2026 returns the whole register, 21,256 rows read through the page's own DataTables endpoint at 500 a page, 43 pages, 0 failures. 25 present, 34 absent, 1 withheld. NOT RATIFIABLE AS IT STANDS, for the same reason as SA but smaller: THE REGISTER MIXES HUMAN AND VETERINARY PRODUCTS and offers no way to separate them. Its own nav shows a VET Medicines tab whose link is a dead #, and the live set contains ATOPICA, a ciclosporin for dogs, and POTENCIL, an amoxicillin plus colistin livestock suspension. Colistin is therefore `scope-unresolved`. Two more things a following harvest needs: the inventory is the free-text `ingredient` composition and NOT the `api` column, which is populated on about 12 rows in 100; and `Registrered` is SAHPRA's own typo covering 74 products, so a filter on the correct spelling alone manufactures 74 false absences. The site still displays a banner apologising for data inconsistencies and promising a fix by 30 June 2023.

Each status reproduces what a named register published on the date shown. Whether a substance may lawfully be sold, imported or administered in a jurisdiction is determined by other rules and is not stated here. Not medical, legal or regulatory advice.

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.